Anti-Human CD123 Recombinant Antibody(Talacotuzumab)
-
产品编号
YR1468
-
别名
科研级 Talacotuzumab ( 塔妥珠单抗 ), Anti-CD123 Recombinant Antibody, Research Grade Talacotuzumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Talacotuzumab ( 塔妥珠单抗 ), Anti-CD123 Recombinant Antibody, Research Grade Talacotuzumab |
| Catalog Number | YR1468 |
| Molecular Name | Talacotuzumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG2 Kappa |
| Formulation | PBS, pH7.5 |
| Background | Zolbetuximab (development code IMAB362) is an experimental monoclonal antibody against isoform 2 of Claudin-18. It is under investigation for the treatment of gastrointestinal adenocarcinomas and pancreatic tumors. IMAB362 was developed by Ganymed Pharmaceuticals AG. The drug is in phase II clinical trials as of January 2013. |
| CAS Number | 1826831-79-1 |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | CD123[Homo sapiens] |
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
